WallStreetZenWallStreetZen

NASDAQ: DCOY
Decoy Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Decoy Therapeutics earnings were -$14.4M for the trailing 12 months ending Jun 30, 2026, with -96.8% growth year over year. The latest DCOY earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$2.4M, up 6.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DCOY reported annual earnings of -$12.5M, with 124.5% growth.

DCOY past earnings growth

How has DCOY's earnings growth performed historically?

Company
-96.83%
Industry
17.35%
Market
92.59%
DCOY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DCOY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

DCOY earnings history

Current Revenue
$227.6k
Current Earnings
-$14.4M
Current Profit Margin
-6,347.9%

DCOY Return on Equity

Current Company
-315.2%
Current Industry
-13.6%
Current Market
33.1%
DCOY's Return on Equity (-315.2%)... subscribe to Premium to read more.
High Return on Equity Performance

DCOY Return on Assets

Current Company
-167.2%
Current Industry
-10.2%
DCOY is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DCOY announces earnings.

DCOY Return on Capital Employed

Current Company
-334.41%
Current Industry
-6.7%
DCOY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DCOY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DCOY-$14.43M-$14.45M-96.83%$12.56
CMND-$7.83M-$7.90MN/A-$187.98
SLXN-$14.12M-$13.96MN/A-$28.43
OGEN-$10.27M-$10.08MN/A-$2.44
VRAX-$5.42M-$5.02MN/A-$12.64
View Top Biotech Stocks

Decoy Therapeutics Earnings Reports & History FAQ

What were Decoy Therapeutics's earnings last quarter?

On DCOY's earnings call on Aug 11, 2026, Decoy Therapeutics (NASDAQ: DCOY) reported Q2 2026 earnings per share (EPS) of -$4.46, up 94.51% year over year. Total DCOY earnings for the quarter were -$2.37 million. In the same quarter last year, Decoy Therapeutics's earnings per share (EPS) was -$81.21.

If you're new to stock investing, here's how to buy Decoy Therapeutics stock.

Is Decoy Therapeutics profitable or losing money?

As of the last Decoy Therapeutics earnings report, Decoy Therapeutics is currently losing money. Decoy Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$14.45 million, a 183.14% increase year over year.

What was DCOY's earnings growth in the past year?

As of Decoy Therapeutics's earnings date in Aug 11, 2026, Decoy Therapeutics's earnings has grown -96.83% year over year. This is 114.18 percentage points lower than the US Biotechnology industry earnings growth rate of 17.35%. DCOY earnings in the past year totalled -$14.45 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.